<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01369693</url>
  </required_header>
  <id_info>
    <org_study_id>2004/3</org_study_id>
    <nct_id>NCT01369693</nct_id>
  </id_info>
  <brief_title>In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus</brief_title>
  <acronym>SMWS03</acronym>
  <official_title>In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Four Brands of Swedish 'Snus' in Regular Snus Users.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Contract Research Organization el AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swedish Match AB</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Contract Research Organization el AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In an open label, randomized, two-way cross-over study, 32 male healthy regular snus users
      will be given repeated doses of four different types of portion snus: &quot;General&quot;, &quot;Catch&quot;,
      &quot;Catch Mini&quot; and &quot;Catch Dry Mini&quot;. Each portion of used snus will be collected and frozen
      (-20 oC) pending analysis of lead (Pb), cadmium (Cd), nicotine and tobacco specific
      nitrosamines (TSNAs). Unused snus is collected and deep frozen for analysis and calculation
      of extracted dose. Calculations of extracted amount of lead, cadmium, nicotine and tobacco
      specific nitrosamines (TSNAs) respectively, will be done for each type of snus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparisons:

      A= &quot;General Portion&quot; 1 g portion snus containing approximately 8 mg nicotine per portion.

      B= &quot;Catch Licorice Portion&quot; 1 g portion snus containing approximately 8 mg nicotine per
      portion.

      C= &quot;Catch Licorice Portion Mini&quot; 0.5 g portion snus containing approximately 4 mg nicotine
      per portion.

      D= &quot;Catch Dry Licorice Portion Mini&quot; 0.3 g portion snus containing approximately 4 mg
      nicotine per portion.

      Swedish portion snus will be administered once every hour (4 administrations/brand) and will
      be kept between the upper lip and the gum for 30 minutes. Preload of own brand each morning.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2004</start_date>
  <completion_date type="Actual">April 2005</completion_date>
  <primary_completion_date type="Actual">August 2004</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In-vivo extraction of cadmium</measure>
    <time_frame>30 minutes' use</time_frame>
    <description>Extracted amount = mean of 10 unused sachets - residual amount</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>in-vivo extraction of tobacco specific nitrosamines (TSNAs)</measure>
    <description>Extracted amount = mean of 10 unused sachets - residual amount in used sachet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-vivo extraction of lead</measure>
    <time_frame>30 minutes' use</time_frame>
    <description>Extracted amount = mean of 10 unused sachets - residual amount in one used sachet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-vivo extraction of nicotine</measure>
    <time_frame>30 minutes' use</time_frame>
    <description>Extracted amount = mean of 10 unused sachets - residual amount in one used sachet</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Smoking Cessation</condition>
  <condition>Smokeless Tobacco</condition>
  <condition>Harm Reduction</condition>
  <arm_group>
    <arm_group_label>General Portion 1 g pouch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Catch Licorice Portion 1 g pouch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Catch Licorice Portion Mini 0.5 g pouch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Catch Licorice Portion Dry Mini 0.3 g pouch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Buccal administration of nicotine</intervention_name>
    <description>Oral pouch, oral sachet, 0.3-1g, single dose. One pouch administered between upper lip and gum over 30 minutes</description>
    <arm_group_label>General Portion 1 g pouch</arm_group_label>
    <arm_group_label>Catch Licorice Portion 1 g pouch</arm_group_label>
    <arm_group_label>Catch Licorice Portion Mini 0.5 g pouch</arm_group_label>
    <arm_group_label>Catch Licorice Portion Dry Mini 0.3 g pouch</arm_group_label>
    <other_name>Smokeless Tobacco</other_name>
    <other_name>ST</other_name>
    <other_name>Potential reduced exposure products</other_name>
    <other_name>PREP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non-smokers, 18 to 50 years of age.

          -  Habitual use of &gt; 7 portions snus daily since minimum 1 year.

          -  Healthy according to the health declaration and interview.

          -  Written informed consent given.

        Exclusion Criteria:

          -  Concurrent participation in another clinical trial.

          -  History of allergy.

          -  History of allergy.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erik Lunell, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Croel AB</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CROel AB</name>
      <address>
        <city>Helsingborg</city>
        <zip>SE25284</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2010</study_first_submitted>
  <study_first_submitted_qc>June 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2011</study_first_posted>
  <last_update_submitted>June 8, 2011</last_update_submitted>
  <last_update_submitted_qc>June 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2011</last_update_posted>
  <responsible_party>
    <name_title>Erik Lunell, MD, PhD</name_title>
    <organization>CROel AB</organization>
  </responsible_party>
  <keyword>smokeless tobacco</keyword>
  <keyword>Nicotine</keyword>
  <keyword>Cadmium</keyword>
  <keyword>lead</keyword>
  <keyword>Tobacco Specific Nitrosamines</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Lobeline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

